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In the classical model of molecular adaptation, a beneficial allele enters a population following a unique mutational event, and then increases in frequency under directional selection. In parallel evolution the same adaptive change at the same site occurs repeatedly in independent lineages exposed to the same selection pressures (Wichman et al. 2000) . Whereas parallel evolution can be easily detected in experimental replicates by survey of DNA sequences during the experiment (Cunningham et al. 1997 , Wichman et al. 2000 , its detection in nature is more difficult because it mostly relies on phylogenetic inferences (Zhang and Kumar 1997; Colosimo et al., 2005) .
Evolution of microbial populations under strong selection provides a useful model for analyzing parallel adaptation because population sizes are large and generation times are short (Wichman et al. 1999 , Boucher et al. 1992 ).
Here we provide direct evidence that two adaptive nucleotide changes in the cytochrome b gene of Plasmodium falciparum (pfcytb) each occurred repeatedly in independent natural lineages exposed to the antimalarial drug atovaquone-proguanil (AP). Resistance of P. falciparum to atovaquone is conferred by single nucleotide polymorphisms (SNP) in the pfcytb gene located on the 6-kb mitochondrial (mt) genome (Korsinczky et al., 2000; Kessl et al. 2005) . Once atovaquone resistance is present, the synergy of the partner drug proguanil is markedly reduced (Fivelman, Adagu and Warhurst 2004) and can lead to treatment failure (Musset et al. 2006) .
To address the evolutionary origins of AP resistance (APR) alleles, we analyzed sequence variation of the mt genome within seven resistant isolates (6 African and 1 Thai) collected at the day of atovaquone (n=1) or AP (n=6) treatment failure (Dfail isolates ; Supplementary Material Online). All the Dfail isolates carried either the a4296g (n=2) or the a4296c (n=5) SNP associated with APR, replacing tyrosine 268 with a cysteine (Y268C) or a serine (Y268S) respectively in the pfcytb gene, (Musset et al. 2006) . For each Dfail isolate, a distinct mt haplotype could be defined with eleven variable sites, including the position 4296 (Fig 1) . As a control, 28 pretreatment 4 isolates from patients successfully cured by AP (D0 control isolates) were selected to match the year and the African country of origin of the Dfail isolates. All carried the wild type pfcytb allele. Two susceptible mt haplotypes, S1 and S2, largely predominated and six haplotypes were found only once, a pattern of mt genetic diversity consistent with a previous study (Joy et al. 2003) . The mean number of pairwise nucleotide differences at 5,819 aligned nucleotide sites was similar between the D0 control and the Dfail isolate groups (2.43 ± 0.99 SE and 2.57 ± 0.88 SE). These data do not support the hypothesis of a recent single origin, where all the APR mt sequences would be expected to be nearly identical. Rather, the distribution of resistant haplotypes in the medianjoining network suggests multiple independent origins of the selected APR alleles (Fig 2) .
D0 parasites isolated before treatment were available for six of the seven failure cases.
Remarkably, the APR allele was not detected in any of the D0 corresponding isolates (Musset et al. 2006) , even using a sensitive assay that detects one APR allele in the presence of up to 10 3 copies of the wild type susceptible allele ( Supplementary Fig S1) . This indicates that the APR allele was either absent or at a very low frequency in isolates before treatment onset. We then investigated the genetic diversity within each pair of D0 and Dfail isolates from the six patients.
Remarkably, with the exception of the polymorphisms at the 4296 site associated with APR, the mt genetic pattern was identical within each pair of isolates (except for patient 2, for which we failed to amplify part of the D0 mt genome ; Fig 3) . Identical nuclear genetic patterns were also observed at five polymorphic nuclear microsatellite loci within pairs for four patients (Fig 3) , indicating genetically identical infections before and after treatment. For the two remaining patients, several coinfecting alleles were detected at more than one locus in D0 isolates. When only predominant alleles were scored, genetic identity was observed. As each of the five African D0 haplotypes was unique (defined by the mt genome and the five microsatellite loci) among 5 D0 control isolates sample (Fig S2) , it is exceedingly unlikely that, in five independent patients, a susceptible and a resistant allele that share an identical haplotype were transmitted by chance to the same host. Taken together, the data presented here show that the two adaptive nucleotide changes in the pfcyb gene, a4296c and a4296g, each occurred repeatedly in different lineages from varied geographic regions. Further, we show that these APR alleles occurred and spread within at least 6 of the 7 patients under atovaquone or AP treatment selection.
Parallel evolution of APR alleles was suspected from the epidemiology of atovaquone resistance (Looareesuwan et al. 1996; Schwartz, Bujanover and Kain 2003) , and is formally demonstrated
here. This situation contrasts with the very few origins and extensive spread of the pfcrt and pfdhfr mutant alleles that determine chloroquine and pyrimethamine resistance, respectively (Cortese et al. 2002; Wootton et al. 2002; Nair et al. 2003; Roper et al. 2003; Ariey et al. 2006 ).
These different patterns in drug resistance evolution might be primarily explained by the different dynamics in the acquisition of the resistance mechanisms. Resistance to chloroquine and pyrimethamine arose by sequential additions of SNPs at the pfcrt and pfdhfr loci, respectively (Anderson and Roper 2005) . It is extremely unlikely that these complex resistant haplotypes occurred during replications within a patient (Hastings 2004) . In contrast, atovaquone resistance is conferred by one SNP that has a major effect on susceptibility to AP (Fivelman, Adagu and Warhurst 2004; Musset et al. 2006) . Theory predicts that the same beneficial allele might enter a population several times by recurrent mutation when the population-level mutation parameter 2N e µ>0.01, where N e is the effective population size and µ the per generation rate of mutation to the beneficial allele (Pennings and Hermisson 2006a) . With an estimated µ for the atovaquone resistance allele of 10 -5 to 10 -8 (Gassis and Rathod 1996) and an estimated N e of 10 5 in the African P. falciparum population (Joy et al. 2003) , 2N e µ is included between 0.002 and 2. This is consistent with our observations of multiple origins of the selected allele. A recent study 6 demonstrated recurrent amplification of the pfmdr1 gene during the evolution of multidrug resistance in malaria parasites from South-East (SE) Asia (Nair et al. 2007 ). Although mutation rates in eukaryotes are generally lower for point mutations than for copy number change (Inoue and Lupski 2002) , our data support that parallel evolution is also likely to occur when adaptation is conferred by simple genetic change like one SNP. However, in contrast with the evolution of pfmdr1 gene copy number in SE Asia, the evolution of APR alleles occurred in the situation where AP pressure on P. falciparum populations is not at a high level nor is it sustained, mainly because the high cost of AP precludes its widespread use. As observed by Nair et al. (2007) , it is expected that the different haplotypes linked to each independent copy of the beneficial allele will be retained and will spread in the population under selection. The signature of such a selective sweep from recurrent beneficial mutation in recombining autosomes, also called "soft sweep", has been described theoretically (Pennings and Hermisson 2006b) . Therefore, methods that detect "soft sweep" and the classical "hard sweep" signatures should both be considered when patterns of DNA polymorphism are used to find novel resistance loci in P. falciparum. 1 1 1 1 1 2 3 3 4 4 4 4 4 4 5 6 7 7 8 8 1 5 6 7 9 6 1 6 2 3 5 6 7 9 4 8 1 1 6 9 6 0 9 7 1 4 6 1 9 8 5 2 8 5 5 4 0 1 9 1 5 9 4 8 3 9 7 9 6 9 2 4 0 4 4 r r r n n s r i i i s s n n n s s i i r 1 1 1 1 1 2 3 3 4 4 4 4 4 4 5 6 7 7 8 8 1 5 6 7 9 6 1 6 2 3 5 6 7 9 4 8 1 1 6 9 6 0 9 7 1 4 6 1 9 8 5 2 8 5 5 4 0 1 9 1 5 9 4 8 3 9 7 9 6 9 2 4 0 4 4 P a Time a H a A --G T G A G T C C C A A G C A G C - 
